Biophysics in the Understanding, Diagnosis, and Treatment of Infectious Diseases Poster Abstracts
93
23-POS
Board 23
Antibiotic Resistance and its Cost in E. Coli Cells Expressing Tap—A Multidrug Efflux
Pump of Mycobacterium Tuberculosis
Jared Mackenzie
1
, Alissa Myrick
2
, Eric Rubin
2
, Frederick Balagadde
1
.
1
KwaZulu-Natal Research Institute for TB and HIV, Durban, KwaZulu-Natal, South
Africa,
2
Harvard School of Public Health, Boston, MA, USA.
Drug resistance is a serious global health problem, with 2 million people each year being
infected with drug resistant bacteria in the US alone. It is believed that efflux pumps are systems
that Tuberculosis microbes as well as other microbes use to survive antibiotics by extruding the
drug molecules that enter the bacteria. To date, the study of the
Mycobacterium tuberculosis
(M.tb)
efflux system is plagued with problems such as functional redundancy that have frustrated
efforts to determine the functions of any single pump. We propose a new approach to
discovering the role of each
M.tbefflux pump. By conditionally expressing
M.tbpumps
in
E.coli
strains that are deficient in transporter proteins and highly sensitive to drugs, we can
characterize each mycobacterial efflux pump in terms of substrate specificity, cognate inhibitors
and efflux capacity. This is done through the use of Microfluidics and novel microchemostat
technology. This technology involves the use of a microfluidic chip that can grow bacterial cells
in perpetuity, allowing us to systematically monitor the long-term dynamics of each tuberculosis
efflux pump, with the ability to resolve gene expression differences between individual cells.
Using these
E.coli
constructs, we have characterized the Tap-like efflux pump Rv1258—
an
M.tb multidrug efflux pump. Cells expressing Tap had increased resistance to streptomycin
and gentamicin relative to wild type cells, with a greater level of resistance observed with the
latter antibiotic. Our results also indicate that whilst conferring increased resistance to
antibiotics, efflux pump expression comes at a fitness cost to the bacteria. This fitness cost
induces a non-growth state that may also independently confer tolerance to antibiotics that
require active microbial growth to be potent.